Robert Karl Malcolm (R Karl Malcolm)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Metabolic Syndrome

Staphylococcus Aureus

Estrogen Receptor

Top Venues

Drug delivery and translational research

This page only lists publications with an associated author ORCID identifier.

Publications

Willem de Laat, Lisa Pagan, Robert Karl Malcolm, Maarten Wiegerinck, Victor Nickolson, Bertine W Huisman, Frederik E Stuurman, Michiel Joost van Esdonk, Naomi Klarenbeek
First-in-human study to assess the pharmacokinetics, tolerability, and safety of single-dose oxybutynin hydrochloride administered via a microprocessor-controlled intravaginal ring. Drug delivery 30 (1) (2023)
Willem de Laat, Lisa Pagan, Robert Karl Malcolm, Maarten Wiegerinck, Victor Nickolson, Bertine W Huisman, Frederik E Stuurman, Michiel Joost van Esdonk, Naomi Klarenbeek
First-in-human study to assess the pharmacokinetics, tolerability, and safety of single-dose oxybutynin hydrochloride administered via a microprocessor-controlled intravaginal ring. Drug delivery 30 (1) (2023)
Willem de Laat, Lisa Pagan, Robert Karl Malcolm, Maarten Wiegerinck, Victor Nickolson, Bertine W Huisman, Frederik E Stuurman, Michiel Joost van Esdonk, Naomi Klarenbeek
First-in-human study to assess the pharmacokinetics, tolerability, and safety of single-dose oxybutynin hydrochloride administered via a microprocessor-controlled intravaginal ring. Drug delivery 30 (1) (2023)
Diarmaid J Murphy, Deanna Lim, Ryan Armstrong, Clare F McCoy, Yahya H Dallal Bashi, Peter Boyd, Tiffany Derrick, Patrick Spence, Bríd Devlin, Robert Karl Malcolm
Refining the in vitro release test method for a dapivirine-releasing vaginal ring to match in vivo performance. Drug delivery and translational research (2021)
Louise Carson, Ruth Merkatz, Elena Martinelli, Peter Boyd, Bruce Variano, Teresa Sallent, Robert Karl Malcolm
The Vaginal Microbiota, Bacterial Biofilms and Polymeric Drug-Releasing Vaginal Rings. Pharmaceutics 13 (5) (2021)